192 related articles for article (PubMed ID: 24493698)
1. Novel target for peptide-based imaging and treatment of brain tumors.
Hyvönen M; Enbäck J; Huhtala T; Lammi J; Sihto H; Weisell J; Joensuu H; Rosenthal-Aizman K; El-Andaloussi S; Langel U; Närvänen A; Bergers G; Laakkonen P
Mol Cancer Ther; 2014 Apr; 13(4):996-1007. PubMed ID: 24493698
[TBL] [Abstract][Full Text] [Related]
2. Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.
Le Joncour V; Filppu P; Hyvönen M; Holopainen M; Turunen SP; Sihto H; Burghardt I; Joensuu H; Tynninen O; Jääskeläinen J; Weller M; Lehti K; Käkelä R; Laakkonen P
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31068339
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
[TBL] [Abstract][Full Text] [Related]
4. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy.
Feng X; Gao X; Kang T; Jiang D; Yao J; Jing Y; Song Q; Jiang X; Liang J; Chen J
Bioconjug Chem; 2015 Aug; 26(8):1850-61. PubMed ID: 26222392
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
6. Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.
Huang M; Xiong C; Lu W; Zhang R; Zhou M; Huang Q; Weinberg J; Li C
Mol Imaging Biol; 2014 Feb; 16(1):74-84. PubMed ID: 23918654
[TBL] [Abstract][Full Text] [Related]
7. Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.
Nevo J; Mattila E; Pellinen T; Yamamoto DL; Sara H; Iljin K; Kallioniemi O; Bono P; Heikkilä P; Joensuu H; Wärri A; Ivaska J
Clin Cancer Res; 2009 Nov; 15(21):6570-81. PubMed ID: 19825952
[TBL] [Abstract][Full Text] [Related]
8. Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P; Lingasamy P; Toome K; Mastandrea I; Rousso-Noori L; Tobi A; Simón-Gracia L; Hunt H; Paiste P; Kotamraju VR; Bergers G; Asser T; Rätsep T; Ruoslahti E; Bjerkvig R; Friedmann-Morvinski D; Teesalu T
J Control Release; 2019 Aug; 308():109-118. PubMed ID: 31255690
[TBL] [Abstract][Full Text] [Related]
9. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy.
Kinnari PJ; Hyvönen ML; Mäkilä EM; Kaasalainen MH; Rivinoja A; Salonen JJ; Hirvonen JT; Laakkonen PM; Santos HA
Biomaterials; 2013 Dec; 34(36):9134-41. PubMed ID: 24008034
[TBL] [Abstract][Full Text] [Related]
10. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
11. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
13. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
14. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
15. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
16. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Rangger C; Helbok A; Sosabowski J; Kremser C; Koehler G; Prassl R; Andreae F; Virgolini IJ; von Guggenberg E; Decristoforo C
Int J Nanomedicine; 2013; 8():4659-71. PubMed ID: 24353415
[TBL] [Abstract][Full Text] [Related]
17. Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.
Zhao L; Zhu J; Gong J; Song N; Wu S; Qiao W; Yang J; Zhu M; Zhao J
J Nanobiotechnology; 2020 Oct; 18(1):143. PubMed ID: 33054757
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.
Madhankumar AB; Slagle-Webb B; Mintz A; Sheehan JM; Connor JR
Mol Cancer Ther; 2006 Dec; 5(12):3162-9. PubMed ID: 17172420
[TBL] [Abstract][Full Text] [Related]
19. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.
Schwartz RB; Holman BL; Polak JF; Garada BM; Schwartz MS; Folkerth R; Carvalho PA; Loeffler JS; Shrieve DC; Black PM; Alexander E
J Neurosurg; 1998 Jul; 89(1):60-8. PubMed ID: 9647173
[TBL] [Abstract][Full Text] [Related]
20. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms.
Liu M; Li C; Pazgier M; Li C; Mao Y; Lv Y; Gu B; Wei G; Yuan W; Zhan C; Lu WY; Lu W
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14321-6. PubMed ID: 20660730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
